Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
1991
Engineering precision nanoparticles for drug delivery
2020 Standout
The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion,
1991
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Improved survival in intestinal ischemia by allopurinol not related to xanthine-oxidase inhibition
1990
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
2003
The occurrence of oxidative stress during reperfusion in experimental animals and men
1991
Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction
2003
Tissue Destruction by Neutrophils
1989 Standout
Reperfusion-induced arrhythmias: A study of the role of xanthine oxidase-derived free radicals in the rat heart
1988
Behaviour of energy metabolites and effect of allopurinol in the “stunned” isovolumic rat heart
1990
Oxidative Stress And Potassium Channel Function
2002
Allopurinol enhanced adenine nucleotide repletion after myocardial ischemia in the isolated rat heart.
1988
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart
1987
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Myocardial Protection with Blood Cardioplegia in Ischemically Injured Hearts: Reduction of Reoxygenation Injury with Allopurinol
1988
Free radicals may contribute to oxidative skeletal muscle fatigue
1991
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Oxygen‐derived free radicals and postischemic myocardial reperfusion: therapeutic implications
1990
A randomized controlled trial of allopurinol in coronary bypass surgery
1991
Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injury
1988
Xanthine Oxidase is Not Responsible for Reoxygenation Injury in Isolated-Perfused Rat Heart
1987
Oxygen-derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”)
1988
Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation
2001
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver.
1988
Substrate Control of Free Radical Generation from Xanthine Oxidase in the Postischemic Heart
1995
Central nervous systems trauma and stroke
1989
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Biochemical Mechanisms for Oxygen Free Radical Formation During Exercise
1990
Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes
2003
MT1-MMP releases latent TGF-β1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1
2008
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Spin Trapping Evidence for Radical Generation by Isolated Hearts and Cultured Heart Cells
1989
Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system
2000
Interaction Between Allopurinol and Copper: Possible Role in Myocardial Protection
1993
Myocardial Reperfusion Injury
2007 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
The role of oxidants and free radicals in reperfusion injury
2006
Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage
1992
Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
2002
On the Specificity of Allopurinol and Oxypurinol as Inhibitors of Xanthine Oxidase. A Pulse Radiolysis Determination of Rate Constants for Reaction of Allopurinol and Oxypurinol with Hydroxyl Radicals
1988
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Role of toxic effects of oxygen in reperfusion damage
1988
Protection afforded by allopurinol in the first 24 hours of coronary occlusion is diminished after 48 hours
1988
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Biomarkers in Heart Failure
2008 Standout
The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion
1988
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Effect of azapropazone and allopurinol on myocardial infarct size in rats
1987
The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
2011
Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1
1988
Effects of allopurinol pretreatment on myocardial ultrastructure and arrhythmias following coronary artery occlusion and reperfusion
1986
Myocardial reperfusion: a double-edged sword?
1985
β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
2011
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model
1986
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
The importance of free radicals and catalytic metal ions in human diseases
1985
H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.
1993 Standout
O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1
2004 StandoutNobel
Konzentration Thiobarbitursäure-reaktiver Substanzen (TBARS) im Serum nach Myokardinfarkt
1986
Ascorbate is an outstanding antioxidant in human blood plasma.
1989 Standout
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart.
1986
Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.
1989
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
1997 Standout
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality.
1987
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
2013 StandoutNobel
Allopurinol Neurocardiac Protection Trial in Infants Undergoing Heart Surgery Using Deep Hypothermic Circulatory Arrest
2001
NAD(P)H Oxidase
2000 Standout
Uric Acid and Survival in Chronic Heart Failure
2003
Myocardial consequences of reperfusion
1987
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
1986 Standout
Age-dependent increase in xanthine oxidoreductase differs in various heart cell types.
1987
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
Oxygen Radicals and Human Disease
1987 Standout
Chronic administration of allopurinol fails to exert any cardioprotective effect in rats submitted to permanent coronary artery ligation
1991
Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.
1987
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts
1986
Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury.
1988
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Effects of allopurinol on myocardial ischemic injury induced by coronary artery ligation and reperfusion
1987
The Mononuclear Molybdenum Enzymes
2014 Standout
Xanthine oxidase inhibition does not limit canine infarct size.
1991
Novel Myofilament Ca 2+ -Sensitizing Property of Xanthine Oxidase Inhibitors
1998
Quantum dot/antibody conjugates for in vivo cytometric imaging in mice
2015 StandoutNobel
Oscillatory Microprocessor for Growth and in Situ Characterization of Semiconductor Nanocrystals
2015 StandoutNobel
Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model.
1995
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.
1988
Allopurinol and oxypurinol are hydroxyl radical scavengers
1987
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow.
1993
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
1986
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Free radicals and myocardial ischemia and reperfusion injury.
1987
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Creatine and Creatinine Metabolism
2000 Standout
Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
1987
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Allopurinol Improves Cardiac Dysfunction After Ischemia-Reperfusion via Reduction of Oxidative Stress in Isolated Perfused Rat Hearts
2003
The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis
1986
Works of R ROY being referenced
Making the cut: Protease-mediated regulation of angiogenesis
2006
Xanthine oxidase as a source of free radical damage in myocardial ischemia
1985